CERS
NASDAQ
$3.15
Cerus Corp (CERS)
Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in Concord, California.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $4.67 (+48.16%)
Market Cap
$617M
Free Cash Flow Yield
-0.20%
Beta (5Y)
1.69
Price Chart
Valuation
Market Cap$617M
P/S2.84
P/B9.17
Profitability
Total Revenue (TTM)$244M
Gross Profit (TTM)$115M
EBITDA-$1.62M
Profit Margin-3.1%
Operating Margin-0.7%
EPS-$0.08
Financial Health
Free Cash Flow Yield-0.20%
Growth & Risk
EPS 5Y CAGR-34.64%
Revenue 5Y CAGR+16.41%
FCF 5Y CAGR-50.33%
Beta (5Y)1.69
Sharpe Ratio1.42